Wound healing work presented at the RCP Innovation in

     Medicine Conference 2018 by Neem Biotech


Neem Biotech, a South Wales based R&D pharmaceutical biotech working in the field of novel antimicrobial drug development, and the Welsh Wound Innovation Centre recently attended the Royal College of Physicians’ Innovation in Medicine Conference 2018 where Neem presented their data around wound-relevant biofilms.


The promising laboratory data presented reinforces the role of quorum sensing inhibition in virulence factor regulation and biofilm disruption, with implications for management of antimicrobial resistance.


Dr Graham Dixon, Neem’s CEO and Prof Keith Harding … read more